Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Hematopoietic stem cell transplantation in sickle cell anemia].
Cornu G, Vermylen C, Ferster A, Brichard B, Ninane J, Ferrant A, Zenebergh A, Maes P, Dhooge C, Benoit Y, Beguin Y, Dresse MF, Sariban E. Cornu G, et al. Among authors: dresse mf. Arch Pediatr. 1999;6 Suppl 2:345s-347s. doi: 10.1016/s0929-693x(99)80463-1. Arch Pediatr. 1999. PMID: 10370531 Clinical Trial. French. No abstract available.
Treatment outcome in infant acute lymphoblastic leukemia. Children Leukemia Cooperative Group--EORTC. European Organization for Research and Treatment of Cancer.
Ferster A, Benoit Y, Francotte N, Dresse MF, Uyttebroeck A, Plouvier E, Thyss A, Lutz P, Marguerite G, Behar C, Mazingue F, Boutard P, Millot F, Rialland X, Mechinaud F, Norton L, Robert A, Otten J, Vilmer E, Philippe N, Waterkeyn C, Suciu S. Ferster A, et al. Among authors: dresse mf. Blood. 2000 Apr 15;95(8):2729-31. Blood. 2000. PMID: 10809540 Free article. No abstract available.
Value of high-dose cytarabine during interval therapy of a Berlin-Frankfurt-Munster-based protocol in increased-risk children with acute lymphoblastic leukemia and lymphoblastic lymphoma: results of the European Organization for Research and Treatment of Cancer 58881 randomized phase III trial.
Millot F, Suciu S, Philippe N, Benoit Y, Mazingue F, Uyttebroeck A, Lutz P, Mechinaud F, Robert A, Boutard P, Marguerite G, Ferster A, Plouvier E, Rialland X, Behard C, Plantaz D, Dresse MF, Philippet P, Norton L, Thyss A, Dastugue N, Waterkeyn C, Vilmer E, Otten J; Children's Leukemia Cooperative Group of the European Organiztaion for Research and Treatment of Cancer. Millot F, et al. Among authors: dresse mf. J Clin Oncol. 2001 Apr 1;19(7):1935-42. doi: 10.1200/JCO.2001.19.7.1935. J Clin Oncol. 2001. PMID: 11283125 Free article. Clinical Trial.
Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience.
Gulbis B, Haberman D, Dufour D, Christophe C, Vermylen C, Kagambega F, Corazza F, Devalck C, Dresse MF, Hunninck K, Klein A, Le PQ, Loop M, Maes P, Philippet P, Sariban E, Van Geet C, Ferster A. Gulbis B, et al. Among authors: dresse mf. Blood. 2005 Apr 1;105(7):2685-90. doi: 10.1182/blood-2004-07-2704. Epub 2004 Dec 16. Blood. 2005. PMID: 15604217 Free article.
[Sickle cell disease: exotic disease or a Belgian public health problem?].
Gulbis B, Ferster A, Kentos A, N'Gay Munungi D, Cotton F, Rongé E, Dresse MF, Bradstreet C, Cochaux P, Vertongen F. Gulbis B, et al. Among authors: dresse mf. Rev Med Brux. 2005 Sep;26(4):S309-13. Rev Med Brux. 2005. PMID: 16240879 Free article. Review. French.
An estimation of the incidence and demographic picture of the major hemoglobinopathies in Belgium (from a confidential inquiry).
Gulbis B, Ferster A, Vermylen C, Dresse MF, Vanderfaeillie A, Delannoy A, Labarque V, Philippet P, Kentos A, Sztern B, Deprijck B, Vertongen F; Red Blood Cell Disorders Subcommittee of the Belgian Haematological Society. Gulbis B, et al. Among authors: dresse mf. Hemoglobin. 2008;32(3):279-85. doi: 10.1080/03630260802004400. Hemoglobin. 2008. PMID: 18473244 Free article.
75 results